Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Among Key Investor Items in CNBC Morning Squawk Retail Investors Gain Direct Access to SpaceX Public Offering Through Major Brokerage Platforms Streaming Giants Gear Up for Weekend Content Showdown Netflix Hulu Prime Video Apple TV Roll Out New Releases Argus Research Highlights LongTerm Growth Potential for Applied Materials AMAT USIran Tensions and Tech Highlights Morning Market Overview Weekly Mortgage Rate Survey Top Lenders See Shakeup After Memorial Day DTE Q1 2026 Earnings EPS Misses Estimates Amid Regulatory and Operational Headwinds MARPS Q4 2025 Earnings Trust Reports 008 EPS Stock Gains 321 Points TRMD Q1 2026 Earnings EPS Surprises to the Upside Amid Cautious Market Sentiment Geron Corporation Q1 2026 Earnings NarrowerThanExpected Loss as Rytelo Commercialization Advances NWS Q1 2026 Earnings EPS Beats Estimates by 12 Amidst Challenging Media Landscape PLDT Inc PHI Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady MITN Slips 05 Amid FixedIncome Volatility Technical Levels Hold Soren Acquisition Corp SORN Holds Steady at 992 Consolidation Phase Ahead Seer Inc SEER Rallies 447 Testing Key Resistance at 196 KFIIR Rights Decline Further Testing Critical Support at 010 Aptiv PLC APTV Surges 27 as Stock Approaches Key Resistance Level Morrisons to Close 100 Stores Amid Rising Costs and Policy Challenges Regency Centers Corporation 625 Series A Cumulative Redeemable Preferred Stock REGCP Q1 2026 Earnings Strong EPS Beat Signals Steady Preferred Dividend Coverage Aurora Innovation AUR Gains 237 as Autonomous Driving Stock Tests Key Resistance VSEC Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Reaction UHS Q1 2026 Earnings EPS Surpasses Estimates Stock Slips Modestly Skyward Specialty Insurance Group Inc Q1 2026 Earnings EPS Beat Drives Modest Stock Gain THCH Q4 2025 Earnings Deep Loss Reported Amidst Limited Disclosure Watts Water Technologies WTS Q1 2026 Earnings Earnings Beat Estimates by Nearly 12 Cyngn Inc CYN Q1 2026 Earnings Narrowerthanexpected loss props up shares Praxis Precision Medicines Inc PRAX Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue